Showing results (151-160 of 276) with videos related to
Sort By:
Pageof 28
Herz|November 5, 1999
Resolution of ST-segment elevation in acute myocardial infarction--early prognostic significance after thrombolytic therapy. Results from the COBALT trialJ Carlsson, U Kamp, D Härtel, et al.Circulation|March 18, 1997
Experimental study of thrombogenicity and foreign body reaction induced by heparin-coated coronary stentsI De Scheerder, K Wang, K Wilczek, et al.Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology|July 1, 1996
Assessment of the optimal atrioventricular delay in dual chamber-paced patients by a portable scintillation probe (VEST)L Mortelmans, W Vanhecke, D Mertens, et al.Coronary Artery Disease|March 1, 1995
Comparison of a low-molecular-weight heparin (nadroparin calcium) and unfractionated heparin as adjunct to coronary thrombolysis with alteplase and aspirin in dogsL Jun, J Arnout, P Vanhove, et al.Journal of the American College of Cardiology|July 1, 1986
Coronary thrombolysis by intravenous infusion of recombinant single chain urokinase-type plasminogen activator or recombinant urokinase in baboons: effect on regional blood flow, infarct size and hemostasisW Flameng, J Vanhaecke, D C Stump, et al.Journal of Clinical Pharmacology|May 12, 2000
Pharmacokinetics and pharmacodynamics of tenecteplase: results from a phase II study in patients with acute myocardial infarctionN B Modi, N L Fox, F W Clow, et al.International Journal of Cardiac Imaging|September 1, 1993
Experimental validation of a new quantitative method for the analysis of infarct size by cardiac perfusion tomography (SPECT)L Mortelmans, J Nuyts, J Vanhaecke, et al.The Biochemical Journal|November 1, 1988
Cyclic GMP-dependent protein kinase stimulates the plasmalemmal Ca2+ pump of smooth muscle via phosphorylation of phosphatidylinositolM Vrolix, L Raeymaekers, F Wuytack, et al.European Journal of Nuclear Medicine|November 1, 1995
Regional myocardial blood flow, glucose utilization and contractile function before and after revascularization and ultrastructural findings in patients with chronic coronary artery diseaseA Maes, W Flameng, M Borgers, et al.Circulation|March 1, 1984
Coronary thrombolysis with intravenously administered human tissue-type plasminogen activator produced by recombinant DNA technologyF Van de Werf, S R Bergmann, K A Fox, et al.Pageof 28